Moderna surges 33.5% after the company outlines plans to expand its mRNA platform beyond vaccines into oncology, autoimmune diseases and cell therapies.
Messenger RNA (mRNA) vaccines are one of the biggest medical breakthroughs of recent years. It was first introduced during ...
The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.
The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...
Shares of Palo Alto Networks, American Airlines Group, and Moderna climbed amid a series of positive catalysts for the ...
When a stock and the analysts covering it disagree this sharply, one of them is about to be wrong.
The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...
Morning Overview on MSN
An mRNA vaccine halved the odds of aggressive melanoma returning after surgery
People treated for aggressive melanoma now have a concrete reason to watch a single experimental combination closely. In a ...
The FDA advisory panel unanimously supported mRNA-1010/mFLUSIVA for adults 50–64 and 65+, and the stock is already reacting ...
A review of data covering billions of doses of mRNA vaccines has found "compelling" evidence that the technology is both safe ...
IFLScience on MSN
Review of mRNA COVID vaccines once again finds they are safe, highly effective, and full of promise
Billions of doses later, a global review has found that mRNA vaccines are safe and highly effective. Not only have they ...
A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results